Literature DB >> 23975614

Thyroid hemorrhage causing airway obstruction after intravenous thrombolysis for acute ischemic stroke.

Raoul Sutter1, Elisabeth Bruder, Mandy Weissenburg, Gianmarco M Balestra.   

Abstract

BACKGROUND: There are several life-threatening complications associated with intravenous thrombolysis after acute ischemic stroke such as symptomatic intracerebral hemorrhage, orolingual angioedema, or less frequent, bleedings of the mucosa or ecchymosis. Aside from these known critical incidents, rare and unfamiliar complications may be even more challenging, as they are unexpected and may mimic events that appear more frequently. We report a rare and unusual acute complication of intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) (0.9 mg/kg) administered for acute ischemic stroke.
METHODS: Medical records, radiologic imaging, and pathologic specimens were reviewed.
RESULTS: A 86-year-old woman developed acute respiratory failure 20 h after thrombolysis with suspected angioedema triggered by intravenous rt-PA. The inspiratory stridor and dyspnea were unresponsive to bronchodilators, corticosteroids, and inhaled adrenaline. After endotracheal intubation, laryngoscopy showed no significant supraglottic narrowing. Thyroidal sonography and cervical computed tomography revealed a thyroidal mass causing a tracheal and vascular compression compatible with thyroidal hemorrhage. Sonography showed a nodular goiter of the right thyroid gland. A total thyroidectomy was performed and histologic analysis confirmed a hemorrhage of the right thyroidal lobe.
CONCLUSIONS: Acute airway obstruction with respiratory failure due to thyroidal hemorrhage after intravenous thrombolysis is an important life-threatening complication, mimicking an anaphylactic reaction or a more frequent orolingual angioedema.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23975614     DOI: 10.1007/s12028-013-9889-z

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  13 in total

1.  Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke.

Authors:  Devin L Brown; William G Barsan; Lynda D Lisabeth; Michael E Gallery; Lewis B Morgenstern
Journal:  Ann Emerg Med       Date:  2005-07       Impact factor: 5.721

2.  Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group.

Authors:  A Jaillard; C Cornu; A Durieux; T Moulin; F Boutitie; K R Lees; M Hommel
Journal:  Stroke       Date:  1999-07       Impact factor: 7.914

3.  Hemorrhage into a thyroid nodule as a cause of thyrotoxicosis.

Authors:  Ibrahim Koral Onal; Selçuk Dağdelen; Ayşegül Atmaca; Omer Karadağ; Nezaket Adalar
Journal:  Endocr Pract       Date:  2006 May-Jun       Impact factor: 3.443

4.  Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study.

Authors:  Michael D Hill; Alastair M Buchan
Journal:  CMAJ       Date:  2005-05-10       Impact factor: 8.262

5.  Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.

Authors:  D Chiu; D Krieger; C Villar-Cordova; S E Kasner; L B Morgenstern; P L Bratina; F M Yatsu; J C Grotta
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

6.  Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?

Authors:  C Berger; M Fiorelli; T Steiner; W R Schäbitz; L Bozzao; E Bluhmki; W Hacke; R von Kummer
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

7.  Cardiac rupture after intravenous t-PA administration in acute ischemic stroke.

Authors:  Amar Dhand; Kazuma Nakagawa; Seema Nagpal; Jeffrey M Gelfand; Anthony S Kim; Wade S Smith; Tarik Tihan
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

8.  Frequency of increased blood pressure levels during systemic thrombolysis and risk of intracerebral hemorrhage.

Authors:  Lars Kellert; Andrea Rocco; Marek Sykora; Werner Hacke; Peter A Ringleb
Journal:  Stroke       Date:  2011-04-28       Impact factor: 7.914

9.  Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke.

Authors:  M D Hill; T Lye; H Moss; P A Barber; A M Demchuk; N J Newcommon; T L Green; C Kenney; A Cole-Haskayne; A M Buchan
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

10.  Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage.

Authors:  M A Sloan; C A Sila; K W Mahaffey; C B Granger; W T Longstreth; P Koudstaal; H D White; J M Gore; M L Simoons; W D Weaver; C L Green; E J Topol; R M Califf
Journal:  Circulation       Date:  1998-10-06       Impact factor: 29.690

View more
  3 in total

1.  Syncope in a patient with spontaneous hemorrhage into a thyroid nodule.

Authors:  Sb Sahin; T Belice; S Ogullar; T Ayaz; E Cure
Journal:  Hippokratia       Date:  2014-04       Impact factor: 0.471

2.  Spontaneous Thyroid Hemorrhage on Chronic Anticoagulation Therapy.

Authors:  Kulothungan Gunasekaran; Kelly M Rudd; Swetha Murthi; Scott Kaatz; Nazir Lone
Journal:  Clin Pract       Date:  2017-02-06

3.  Acute diffuse and transient thyroid swelling after intravenous thrombolysis for acute ischemic stroke: A case report.

Authors:  Liuhong Shi; Caoxin Yan; Wen Xu; Pintong Huang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.